Author:
Scott Christopher Thomas,Baker Monya
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference8 articles.
1. European Medicines Agency (EMEA). Reflection Paper on Methodological Issues in Confirmatory Clinical Trials with Flexible Design and Analysis Plan (EMEA, London, March 2006).
http://www.emea.eu.int/pdfs/human/ewp/245902en.pdf
2. Emerson, S.S. Issues in the use of adaptive clinical trial designs. Statist. Med. 25, 3270–3296 (2006).
3. Rosenberger, W. & Palmer, C. Ethics and practice: Alternative designs for Phase III randomized clinical trials. Controlled Clinical Trials 20, 172–186 (1999).
4. Krams M. et al. Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke 34, 2543–2548 (2003).
5. Kaitin, K.I. et al. Fastest drug developers consistently best peers on key performance metrics. Tufts Center for the Study of Drug Development Impact Report 8, (2006).
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献